CFGS
TMO icon

Concourse Financial Group Securities’s Thermo Fisher Scientific TMO Stock Holding History

Concourse Financial Group Securities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,580
Closed -$5.5M – 1869
2024
Q4 		$5.5M Sell
9,580
-442
-4% -$243K 0.31% 74
2024
Q3 		$6.2M Sell
10,022
-625
-6% -$370K 0.37% 54
2024
Q2 		$5.89M Sell
10,647
-45
-0.4% -$25.8K 0.37% 58
2024
Q1 		$6.22M Buy
10,692
+86
+0.8% +$48.3K 0.4% 51
2023
Q4 		$5.63M Sell
10,606
-734
-6% -$355K 0.4% 51
2023
Q3 		$5.74M Buy
11,340
+154
+1% +$82.1K 0.45% 43
2023
Q2 		$5.84M Buy
11,186
+498
+5% +$269K 0.44% 45
2023
Q1 		$6.16M Sell
10,688
-260
-2% -$147K 0.48% 39
2022
Q4 		$6.03M Buy
10,948
+87
+0.8% +$46.1K 0.49% 37
2022
Q3 		$5.51M Sell
10,861
-166
-2% -$92.9K 0.52% 28
2022
Q2 		$5.99M Sell
11,027
-786
-7% -$433K 0.51% 34
2022
Q1 		$6.98M Sell
11,813
-508
-4% -$292K 0.51% 33
2021
Q4 		$8.22M Buy
12,321
+677
+6% +$423K 0.47% 43
2021
Q3 		$6.66M Sell
11,644
-243
-2% -$133K 0.41% 52
2021
Q2 		$6M Buy
11,887
+1,486
+14% +$701K 0.38% 56
2021
Q1 		$4.75M Buy
10,401
+188
+2% +$89.7K 0.33% 65
2020
Q4 		$4.76M Buy
10,213
+491
+5% +$230K 0.36% 57
2020
Q3 		$4.29M Buy
9,722
+104
+1% +$43K 0.37% 56
2020
Q2 		$3.49M Sell
9,618
-400
-4% -$134K 0.34% 63
2020
Q1 		$2.84M Buy
10,018
+1,947
+24% +$614K 0.31% 69
2019
Q4 		$2.62M Buy
8,071
+5,919
+275% +$1.79M 0.26% 82
2019
Q3 		$627K Sell
2,152
-5,811
-73% -$1.66M 0.16% 112
2019
Q2 		$2.34M Buy
7,963
+641
+9% +$177K 0.24% 79
2019
Q1 		$2M Sell
7,322
-432
-6% -$108K 0.21% 90
2018
Q4 		$1.74M Buy
7,754
+3,746
+93% +$879K 0.21% 94
2018
Q3 		$979K Buy
+4,008
New +$922K 0.28% 80

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Concourse Financial Group Securities's TMO Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 9,580 shares — an estimated $5.5M sold.

Concourse Financial Group Securities first reported a position in TMO in Q3 2018 and held it in 26 quarters. The position peaked at $8.22M in Q4 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 9,580 Thermo Fisher Scientific shares in Q1 2025, an estimated $5.5M.
  • Concourse Financial Group Securities first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Thermo Fisher Scientific position peaked at $8.22M in Q4 2021.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.